LIFESTYLE NEWS - Drug company Pfizer has announced it is pulling out of research into drugs to treat Alzheimer's disease.
The US-based pharmaceutical giant said it would be ending its neuroscience discovery programmes following a review, and 300 jobs would be lost.
The Alzheimer's Society called the news "disappointing" and a "heavy blow" to those living with dementia.
Companies should be encouraged to invest in research into neuroscience, Alzheimer's Research UK said.
The move means Pfizer will also stop looking for treatments for Parkinson's disease, but the company said it planned to create a new fund dedicated to neuroscience research in the future.
Pfizer pulls out of research into Alzheimer's
Share
Pfizer has announced it is pulling out of research into drugs to treat Alzheimer's disease.
Read more about:
research
alzheimers
pfizer
Posted on: 09:40 Thu, 11 January 2018
More Group Editors Publications & Online Platforms
Knysna-Plett Herald proudly displays the “FAIR” stamp of the Press Council of South Africa, indicating our commitment to adhere to the Code of Ethics for Print and online media which prescribes that our reportage is truthful, accurate and fair. Should you wish to lodge a complaint about our news coverage, please lodge a complaint on the Press Council’s website, www.presscouncil.org.za or email the complaint to enquiries@ombudsman.org.za. Contact the Press Council on 0114843612.
Copyright 2025 Group Editors Company (Pty) Ltd, Registration Number 1963/002133/07 t/a Knysna-Plett Herald
